缺血性中风患者的强化与非强化他类药物治疗:系统性审查和元分析
Felipe Moraes Costa1, Kaike Lobo1, João Lucas Lalor Tavares1
1Faculty of Medicine, State University of Pará, Perebebuí 2623, Belém, Pará, Brazil.
概括
强化他类药物治疗在三个月内改善了缺血性中风患者的功能结果. 然而,它与更高的脑内出血风险有关,对中风复发或死亡率没有显著影响.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 临床研究 临床研究
背景情况:
- 缺血性中风是全球死亡和残疾的主要原因.
- 立方体治疗是治疗缺血性中风的基石.
- 在急性阶段,他类药物治疗的最佳强度尚不清楚.
研究的目的:
- 在急性缺血性中风患者中,评估强化他类药物治疗与非强化治疗的疗效.
- 评估他类药物强度对功能恢复和临床结果的影响.
- 确定这种人群中强化他类药物治疗的安全概况.
主要方法:
- 在四个数据库中进行了系统的文献搜索.
- 包括的研究包括随机对照试验和观察性研究.
- 进行了元分析,使用随机效应模型.
主要成果:
- 三个月后,强化他类药物治疗显著改善了功能结果 (mRS 0-2和0-3).
- 在强化使用他类药物治疗时,观察到脑内出血的发生率更高.
- 在中风复发,其他出血事件,急性冠状动脉综合征或全因死亡率方面没有发现显著差异.
结论:
- 强化他类药物治疗可提高急性缺血性中风患者的功能恢复.
- 脑内出血的风险增加需要仔细考虑.
- 强化他类药物治疗似乎不会增加中风复发率或死亡率.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
890
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
890
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K


